# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA1996872 | SID50125741 | Potency | 33.498 | uM | ALA2354254 | inconclusive | nM | Homo sapiens | |||
2. | ALA1996872 | SID50125741 | Potency | 29.855 | uM | ALA2354221 | inconclusive | nM | Homo sapiens | |||
3. | ALA1996872 | SID50125741 | Potency | 36.125 | uM | ALA1963912 | inconclusive | nM | ||||
4. | ALA1996872 | SID50125741 | inhibition | = | -0.13 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
5. | ALA1996872 | SID50125741 | Inhibition | = | 10.105 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 | |||
6. | ALA1996872 | SID50125741 | inhibition | = | -0.13 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
7. | ALA1996872 | SID50125741 | inhibition | = | 8.76 | % | ALA4808150 | % | Homo sapiens | |||
8. | ALA1996872 | SID50125741 | inhibition | = | 14.43 | % | ALA4808149 | % | Homo sapiens | |||
9. | ALA1996872 | SID50125741 | Inhibition | = | -14.37 | % | ALA4303805 | % | Severe acute respiratory syndrome coronavirus 2 | |||
10. | ALA1996872 | SID50125741 | MIC | = | 0.02 | ug ml-1 | ALA4270933 | ug.mL-1 | Bacillus subtilis | |||
11. | ALA1996872 | SID50125741 | MIC | = | 0.02 | ug ml-1 | ALA4270934 | ug.mL-1 | Escherichia coli | |||
12. | ALA1996872 | SID50125741 | MIC | = | 0.02 | ug ml-1 | ALA4270935 | ug.mL-1 | Pseudomonas aeruginosa | |||
13. | ALA1996872 | SID50125741 | MIC | = | 0.02 | ug ml-1 | ALA4270936 | ug.mL-1 | Staphylococcus aureus | |||
14. | ALA1996872 | SID50125741 | MIC | = | 0.22 | ug ml-1 | ALA5260994 | ug.mL-1 | Saccharomyces cerevisiae | |||
15. | ALA1996872 | SID50125741 | Potency | 5.726 | uM | ALA1964081 | inactive | nM | Rattus norvegicus |